nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—SLC6A2—hypertension	0.0683	0.223	CbGaD
Pseudoephedrine—Isoxsuprine—Labetalol—hypertension	0.0676	0.497	CrCrCtD
Pseudoephedrine—ADRA1A—hypertension	0.0481	0.157	CbGaD
Pseudoephedrine—Isoxsuprine—Propranolol—hypertension	0.0467	0.343	CrCrCtD
Pseudoephedrine—SLC6A3—hypertension	0.0347	0.114	CbGaD
Pseudoephedrine—ADRA2A—hypertension	0.034	0.111	CbGaD
Pseudoephedrine—ADRB1—hypertension	0.034	0.111	CbGaD
Pseudoephedrine—TNF—hypertension	0.0323	0.105	CbGaD
Pseudoephedrine—ADRB2—hypertension	0.0286	0.0935	CbGaD
Pseudoephedrine—SLC6A4—hypertension	0.026	0.0849	CbGaD
Pseudoephedrine—Atomoxetine—Propranolol—hypertension	0.0216	0.159	CrCrCtD
Pseudoephedrine—SLC6A2—Guanadrel—hypertension	0.0157	0.0442	CbGbCtD
Pseudoephedrine—ADRB2—Esmolol—hypertension	0.0142	0.04	CbGbCtD
Pseudoephedrine—ADRB1—Esmolol—hypertension	0.014	0.0394	CbGbCtD
Pseudoephedrine—SLC6A2—Guanethidine—hypertension	0.0119	0.0335	CbGbCtD
Pseudoephedrine—ADRB2—Labetalol—hypertension	0.0108	0.0303	CbGbCtD
Pseudoephedrine—ADRB2—Nadolol—hypertension	0.0108	0.0303	CbGbCtD
Pseudoephedrine—ADRB2—Nebivolol—hypertension	0.0108	0.0303	CbGbCtD
Pseudoephedrine—ADRB1—Nebivolol—hypertension	0.0106	0.0299	CbGbCtD
Pseudoephedrine—ADRB1—Nadolol—hypertension	0.0106	0.0299	CbGbCtD
Pseudoephedrine—ADRB1—Labetalol—hypertension	0.0106	0.0299	CbGbCtD
Pseudoephedrine—ADRB2—Acebutolol—hypertension	0.00984	0.0277	CbGbCtD
Pseudoephedrine—ADRB1—Acebutolol—hypertension	0.00969	0.0273	CbGbCtD
Pseudoephedrine—ADRB2—Pindolol—hypertension	0.00915	0.0258	CbGbCtD
Pseudoephedrine—ADRB2—Metoprolol—hypertension	0.00915	0.0258	CbGbCtD
Pseudoephedrine—ADRB1—Metoprolol—hypertension	0.00901	0.0254	CbGbCtD
Pseudoephedrine—ADRB1—Pindolol—hypertension	0.00901	0.0254	CbGbCtD
Pseudoephedrine—ADRB2—Betaxolol—hypertension	0.00815	0.023	CbGbCtD
Pseudoephedrine—ADRA2A—Methyldopa—hypertension	0.00811	0.0229	CbGbCtD
Pseudoephedrine—ADRB1—Betaxolol—hypertension	0.00803	0.0226	CbGbCtD
Pseudoephedrine—ADRB2—Penbutolol—hypertension	0.00746	0.021	CbGbCtD
Pseudoephedrine—ADRA2A—Guanabenz—hypertension	0.00742	0.0209	CbGbCtD
Pseudoephedrine—ADRB1—Penbutolol—hypertension	0.00734	0.0207	CbGbCtD
Pseudoephedrine—ADRA2A—Guanfacine—hypertension	0.0069	0.0194	CbGbCtD
Pseudoephedrine—ADRA1A—Terazosin—hypertension	0.00622	0.0175	CbGbCtD
Pseudoephedrine—ADRA2A—Fenoldopam—hypertension	0.00587	0.0165	CbGbCtD
Pseudoephedrine—ADRA1A—Fenoldopam—hypertension	0.00562	0.0159	CbGbCtD
Pseudoephedrine—ADRA2A—Doxazosin—hypertension	0.00541	0.0153	CbGbCtD
Pseudoephedrine—ADRB2—Timolol—hypertension	0.00525	0.0148	CbGbCtD
Pseudoephedrine—ADRA1A—Doxazosin—hypertension	0.00519	0.0146	CbGbCtD
Pseudoephedrine—ADRB1—Timolol—hypertension	0.00517	0.0146	CbGbCtD
Pseudoephedrine—ADRB2—Carvedilol—hypertension	0.00509	0.0143	CbGbCtD
Pseudoephedrine—ADRB1—Carvedilol—hypertension	0.00501	0.0141	CbGbCtD
Pseudoephedrine—ADRB2—Propranolol—hypertension	0.00468	0.0132	CbGbCtD
Pseudoephedrine—ADRB1—Propranolol—hypertension	0.00461	0.013	CbGbCtD
Pseudoephedrine—ADRA2A—Prazosin—hypertension	0.00445	0.0125	CbGbCtD
Pseudoephedrine—ADRA1A—Prazosin—hypertension	0.00426	0.012	CbGbCtD
Pseudoephedrine—ADRA2A—Carvedilol—hypertension	0.00384	0.0108	CbGbCtD
Pseudoephedrine—SLC6A2—Clonidine—hypertension	0.00374	0.0105	CbGbCtD
Pseudoephedrine—ADRA1A—Nicardipine—hypertension	0.00368	0.0104	CbGbCtD
Pseudoephedrine—ADRA1A—Carvedilol—hypertension	0.00368	0.0104	CbGbCtD
Pseudoephedrine—ADRA2A—Clonidine—hypertension	0.00337	0.0095	CbGbCtD
Pseudoephedrine—ADRA1A—Clonidine—hypertension	0.00323	0.0091	CbGbCtD
Pseudoephedrine—SLC6A4—Verapamil—hypertension	0.00321	0.00906	CbGbCtD
Pseudoephedrine—CYP2D6—Nebivolol—hypertension	0.0027	0.00761	CbGbCtD
Pseudoephedrine—CYP2D6—Labetalol—hypertension	0.0027	0.00761	CbGbCtD
Pseudoephedrine—CYP2D6—Acebutolol—hypertension	0.00247	0.00696	CbGbCtD
Pseudoephedrine—CYP2D6—Metoprolol—hypertension	0.00229	0.00647	CbGbCtD
Pseudoephedrine—CYP2D6—Pindolol—hypertension	0.00229	0.00647	CbGbCtD
Pseudoephedrine—CYP2D6—Betaxolol—hypertension	0.00204	0.00576	CbGbCtD
Pseudoephedrine—IL2—blood vessel—hypertension	0.00193	0.0828	CbGeAlD
Pseudoephedrine—CYP2D6—Doxazosin—hypertension	0.0018	0.00507	CbGbCtD
Pseudoephedrine—SLC6A2—locus ceruleus—hypertension	0.00175	0.0752	CbGeAlD
Pseudoephedrine—CYP2D6—Diltiazem—hypertension	0.00174	0.0049	CbGbCtD
Pseudoephedrine—MAOA—locus ceruleus—hypertension	0.00161	0.0693	CbGeAlD
Pseudoephedrine—CYP2D6—Bepridil—hypertension	0.00155	0.00437	CbGbCtD
Pseudoephedrine—CYP2D6—Irbesartan—hypertension	0.00142	0.004	CbGbCtD
Pseudoephedrine—CYP2D6—Amlodipine—hypertension	0.00139	0.00392	CbGbCtD
Pseudoephedrine—SLC6A2—sympathetic nervous system—hypertension	0.00138	0.0594	CbGeAlD
Pseudoephedrine—CYP2D6—Felodipine—hypertension	0.00134	0.00378	CbGbCtD
Pseudoephedrine—CYP2D6—Timolol—hypertension	0.00132	0.00371	CbGbCtD
Pseudoephedrine—CYP2D6—Nifedipine—hypertension	0.0013	0.00365	CbGbCtD
Pseudoephedrine—CYP2D6—Carvedilol—hypertension	0.00128	0.0036	CbGbCtD
Pseudoephedrine—CYP2D6—Nicardipine—hypertension	0.00128	0.0036	CbGbCtD
Pseudoephedrine—CYP2D6—Propranolol—hypertension	0.00117	0.00331	CbGbCtD
Pseudoephedrine—CYP2D6—Captopril—hypertension	0.00116	0.00327	CbGbCtD
Pseudoephedrine—CYP2D6—Clonidine—hypertension	0.00112	0.00316	CbGbCtD
Pseudoephedrine—CYP2D6—Atorvastatin—hypertension	0.000999	0.00281	CbGbCtD
Pseudoephedrine—NFATC1—heart—hypertension	0.000996	0.0428	CbGeAlD
Pseudoephedrine—NFATC1—cardiovascular system—hypertension	0.00094	0.0404	CbGeAlD
Pseudoephedrine—SLC6A2—autonomic nervous system—hypertension	0.00093	0.04	CbGeAlD
Pseudoephedrine—IL2—heart—hypertension	0.000911	0.0391	CbGeAlD
Pseudoephedrine—IL2—cardiovascular system—hypertension	0.00086	0.0369	CbGeAlD
Pseudoephedrine—IL2—kidney—hypertension	0.000841	0.0361	CbGeAlD
Pseudoephedrine—CYP2D6—Verapamil—hypertension	0.000806	0.00227	CbGbCtD
Pseudoephedrine—NFATC1—adrenal gland—hypertension	0.000744	0.0319	CbGeAlD
Pseudoephedrine—ADRB2—Treprostinil—Nadolol—hypertension	0.000619	1	CbGdCrCtD
Pseudoephedrine—IL2—endocrine gland—hypertension	0.00059	0.0253	CbGeAlD
Pseudoephedrine—NFATC1—central nervous system—hypertension	0.000581	0.025	CbGeAlD
Pseudoephedrine—IL2—central nervous system—hypertension	0.000532	0.0228	CbGeAlD
Pseudoephedrine—CYP2D6—urine—hypertension	0.000415	0.0178	CbGeAlD
Pseudoephedrine—ADRB1—cardiac ventricle—hypertension	0.000348	0.0149	CbGeAlD
Pseudoephedrine—ADRB1—myocardium—hypertension	0.000327	0.0141	CbGeAlD
Pseudoephedrine—Bethanidine—KCNJ1—hypertension	0.000326	0.114	CrCbGaD
Pseudoephedrine—SLC6A3—brainstem—hypertension	0.000278	0.012	CbGeAlD
Pseudoephedrine—MAOA—cardiac ventricle—hypertension	0.000273	0.0117	CbGeAlD
Pseudoephedrine—MAOA—myocardium—hypertension	0.000256	0.011	CbGeAlD
Pseudoephedrine—SLC6A4—brainstem—hypertension	0.000255	0.011	CbGeAlD
Pseudoephedrine—Etomidate—CYP11B1—hypertension	0.000234	0.0819	CrCbGaD
Pseudoephedrine—ADRB1—heart—hypertension	0.000228	0.00981	CbGeAlD
Pseudoephedrine—SLC6A2—brainstem—hypertension	0.000225	0.00965	CbGeAlD
Pseudoephedrine—Etomidate—CYP11B2—hypertension	0.00022	0.077	CrCbGaD
Pseudoephedrine—ADRB1—cardiovascular system—hypertension	0.000216	0.00926	CbGeAlD
Pseudoephedrine—ADRA1A—brainstem—hypertension	0.000209	0.00897	CbGeAlD
Pseudoephedrine—MAOA—brainstem—hypertension	0.000207	0.00889	CbGeAlD
Pseudoephedrine—ADRB1—cardiac atrium—hypertension	0.000195	0.00839	CbGeAlD
Pseudoephedrine—SLC6A2—decidua—hypertension	0.000189	0.00811	CbGeAlD
Pseudoephedrine—MAOA—nephron tubule—hypertension	0.000188	0.00808	CbGeAlD
Pseudoephedrine—MAOA—adrenal cortex—hypertension	0.000185	0.00795	CbGeAlD
Pseudoephedrine—ADRA1A—heart—hypertension	0.000181	0.00776	CbGeAlD
Pseudoephedrine—MAOA—heart—hypertension	0.000179	0.00769	CbGeAlD
Pseudoephedrine—MAOA—decidua—hypertension	0.000174	0.00748	CbGeAlD
Pseudoephedrine—ADRA1A—cardiovascular system—hypertension	0.00017	0.00732	CbGeAlD
Pseudoephedrine—MAOA—cardiovascular system—hypertension	0.000169	0.00725	CbGeAlD
Pseudoephedrine—MAOA—kidney—hypertension	0.000165	0.0071	CbGeAlD
Pseudoephedrine—Metaraminol—ADRA1A—hypertension	0.000164	0.0574	CrCbGaD
Pseudoephedrine—MAOA—cortex of kidney—hypertension	0.000161	0.00691	CbGeAlD
Pseudoephedrine—SLC6A2—medulla oblongata—hypertension	0.000157	0.00673	CbGeAlD
Pseudoephedrine—MAOA—cardiac atrium—hypertension	0.000153	0.00657	CbGeAlD
Pseudoephedrine—ADRB1—endocrine gland—hypertension	0.000148	0.00635	CbGeAlD
Pseudoephedrine—SLC6A2—adrenal gland—hypertension	0.000145	0.00623	CbGeAlD
Pseudoephedrine—MAOA—medulla oblongata—hypertension	0.000144	0.0062	CbGeAlD
Pseudoephedrine—SLC6A4—endocrine gland—hypertension	0.000143	0.00613	CbGeAlD
Pseudoephedrine—SLC6A3—central nervous system—hypertension	0.00014	0.00603	CbGeAlD
Pseudoephedrine—ADRA2A—heart—hypertension	0.000137	0.0059	CbGeAlD
Pseudoephedrine—Etomidate—ADRA2B—hypertension	0.000136	0.0474	CrCbGaD
Pseudoephedrine—ADRA1A—adrenal gland—hypertension	0.000135	0.00579	CbGeAlD
Pseudoephedrine—Bethanidine—SLC6A2—hypertension	0.000134	0.0468	CrCbGaD
Pseudoephedrine—MAOA—adrenal gland—hypertension	0.000134	0.00574	CbGeAlD
Pseudoephedrine—ADRA2A—decidua—hypertension	0.000134	0.00574	CbGeAlD
Pseudoephedrine—ADRB1—central nervous system—hypertension	0.000133	0.00572	CbGeAlD
Pseudoephedrine—Atomoxetine—NPY1R—hypertension	0.000131	0.0459	CrCbGaD
Pseudoephedrine—SLC6A4—central nervous system—hypertension	0.000129	0.00553	CbGeAlD
Pseudoephedrine—SLC6A2—endocrine gland—hypertension	0.000126	0.0054	CbGeAlD
Pseudoephedrine—ADRA2A—cortex of kidney—hypertension	0.000123	0.0053	CbGeAlD
Pseudoephedrine—CYP2D6—brainstem—hypertension	0.000123	0.00528	CbGeAlD
Pseudoephedrine—Mephentermine—ADRA1A—hypertension	0.000122	0.0425	CrCbGaD
Pseudoephedrine—ADRA2A—cardiac atrium—hypertension	0.000117	0.00504	CbGeAlD
Pseudoephedrine—ADRA1A—endocrine gland—hypertension	0.000117	0.00502	CbGeAlD
Pseudoephedrine—MAOA—endocrine gland—hypertension	0.000116	0.00498	CbGeAlD
Pseudoephedrine—SLC6A2—central nervous system—hypertension	0.000113	0.00487	CbGeAlD
Pseudoephedrine—ADRA2A—medulla oblongata—hypertension	0.000111	0.00475	CbGeAlD
Pseudoephedrine—ADRA1A—central nervous system—hypertension	0.000105	0.00452	CbGeAlD
Pseudoephedrine—MAOA—central nervous system—hypertension	0.000104	0.00448	CbGeAlD
Pseudoephedrine—ADRA2A—adrenal gland—hypertension	0.000102	0.0044	CbGeAlD
Pseudoephedrine—CYP2D6—kidney—hypertension	9.82e-05	0.00422	CbGeAlD
Pseudoephedrine—Ephedrine—SLC6A2—hypertension	9.03e-05	0.0316	CrCbGaD
Pseudoephedrine—ADRA2A—endocrine gland—hypertension	8.89e-05	0.00382	CbGeAlD
Pseudoephedrine—Benzyl alcohol—ALDH2—hypertension	8.82e-05	0.0308	CrCbGaD
Pseudoephedrine—Phenylpropanolamine—SLC6A2—hypertension	8.1e-05	0.0283	CrCbGaD
Pseudoephedrine—ADRA2A—central nervous system—hypertension	8.01e-05	0.00344	CbGeAlD
Pseudoephedrine—Phentermine—SLC6A2—hypertension	7.22e-05	0.0253	CrCbGaD
Pseudoephedrine—Dextroamphetamine—SLC6A2—hypertension	6.89e-05	0.0241	CrCbGaD
Pseudoephedrine—CYP2D6—endocrine gland—hypertension	6.88e-05	0.00296	CbGeAlD
Pseudoephedrine—Ephedrine—ADRA1A—hypertension	6.36e-05	0.0223	CrCbGaD
Pseudoephedrine—CYP2D6—central nervous system—hypertension	6.2e-05	0.00266	CbGeAlD
Pseudoephedrine—Methamphetamine—ADRA2B—hypertension	5.85e-05	0.0205	CrCbGaD
Pseudoephedrine—Etomidate—CYP19A1—hypertension	5.82e-05	0.0204	CrCbGaD
Pseudoephedrine—Phenylpropanolamine—ADRA1A—hypertension	5.71e-05	0.02	CrCbGaD
Pseudoephedrine—Amphetamine—SLC6A2—hypertension	5.55e-05	0.0194	CrCbGaD
Pseudoephedrine—Methamphetamine—SLC6A2—hypertension	5.14e-05	0.018	CrCbGaD
Pseudoephedrine—Atomoxetine—SLC6A2—hypertension	5.06e-05	0.0177	CrCbGaD
Pseudoephedrine—Dextroamphetamine—ADRA1A—hypertension	4.85e-05	0.017	CrCbGaD
Pseudoephedrine—Phenylpropanolamine—SLC6A3—hypertension	4.12e-05	0.0144	CrCbGaD
Pseudoephedrine—Phenylpropanolamine—ADRA2A—hypertension	4.04e-05	0.0141	CrCbGaD
Pseudoephedrine—Phenylpropanolamine—ADRB1—hypertension	4.03e-05	0.0141	CrCbGaD
Pseudoephedrine—Ephedrine—ADRB2—hypertension	3.78e-05	0.0132	CrCbGaD
Pseudoephedrine—Phentermine—SLC6A3—hypertension	3.67e-05	0.0128	CrCbGaD
Pseudoephedrine—Dextroamphetamine—SLC6A3—hypertension	3.5e-05	0.0123	CrCbGaD
Pseudoephedrine—Phenylpropanolamine—ADRB2—hypertension	3.39e-05	0.0119	CrCbGaD
Pseudoephedrine—Nausea—Metoprolol—hypertension	3.25e-05	0.000352	CcSEcCtD
Pseudoephedrine—Nausea—Guanabenz—hypertension	3.25e-05	0.000352	CcSEcCtD
Pseudoephedrine—Body temperature increased—Clonidine—hypertension	3.25e-05	0.000351	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Telmisartan—hypertension	3.24e-05	0.00035	CcSEcCtD
Pseudoephedrine—Palpitations—Ramipril—hypertension	3.23e-05	0.00035	CcSEcCtD
Pseudoephedrine—Insomnia—Betaxolol—hypertension	3.23e-05	0.000349	CcSEcCtD
Pseudoephedrine—Dyspepsia—Hydrochlorothiazide—hypertension	3.23e-05	0.000349	CcSEcCtD
Pseudoephedrine—Decreased appetite—Perindopril—hypertension	3.23e-05	0.000349	CcSEcCtD
Pseudoephedrine—Nervousness—Lisinopril—hypertension	3.22e-05	0.000349	CcSEcCtD
Pseudoephedrine—Dizziness—Indapamide—hypertension	3.22e-05	0.000348	CcSEcCtD
Pseudoephedrine—Dizziness—Diltiazem—hypertension	3.22e-05	0.000348	CcSEcCtD
Pseudoephedrine—Decreased appetite—Irbesartan—hypertension	3.22e-05	0.000348	CcSEcCtD
Pseudoephedrine—Vertigo—Timolol—hypertension	3.21e-05	0.000348	CcSEcCtD
Pseudoephedrine—Vomiting—Propranolol—hypertension	3.2e-05	0.000346	CcSEcCtD
Pseudoephedrine—Decreased appetite—Hydrochlorothiazide—hypertension	3.19e-05	0.000345	CcSEcCtD
Pseudoephedrine—Muscle spasms—Lisinopril—hypertension	3.19e-05	0.000345	CcSEcCtD
Pseudoephedrine—Dizziness—Carvedilol—hypertension	3.19e-05	0.000345	CcSEcCtD
Pseudoephedrine—Dyspnoea—Betaxolol—hypertension	3.19e-05	0.000345	CcSEcCtD
Pseudoephedrine—Pain—Perindopril—hypertension	3.18e-05	0.000343	CcSEcCtD
Pseudoephedrine—Rash—Propranolol—hypertension	3.17e-05	0.000343	CcSEcCtD
Pseudoephedrine—Dermatitis—Propranolol—hypertension	3.17e-05	0.000342	CcSEcCtD
Pseudoephedrine—Body temperature increased—Trandolapril—hypertension	3.17e-05	0.000342	CcSEcCtD
Pseudoephedrine—Pain—Irbesartan—hypertension	3.17e-05	0.000342	CcSEcCtD
Pseudoephedrine—Palpitations—Timolol—hypertension	3.16e-05	0.000342	CcSEcCtD
Pseudoephedrine—Dizziness—Doxazosin—hypertension	3.15e-05	0.000341	CcSEcCtD
Pseudoephedrine—Body temperature increased—Enalapril—hypertension	3.15e-05	0.000341	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Captopril—hypertension	3.15e-05	0.000341	CcSEcCtD
Pseudoephedrine—Insomnia—Losartan—hypertension	3.15e-05	0.000341	CcSEcCtD
Pseudoephedrine—Dyspepsia—Betaxolol—hypertension	3.15e-05	0.00034	CcSEcCtD
Pseudoephedrine—Pain—Hydrochlorothiazide—hypertension	3.14e-05	0.000339	CcSEcCtD
Pseudoephedrine—Decreased appetite—Furosemide—hypertension	3.14e-05	0.000339	CcSEcCtD
Pseudoephedrine—Chest pain—Ramipril—hypertension	3.12e-05	0.000337	CcSEcCtD
Pseudoephedrine—Dizziness—Fosinopril—hypertension	3.11e-05	0.000337	CcSEcCtD
Pseudoephedrine—Tremor—Lisinopril—hypertension	3.11e-05	0.000336	CcSEcCtD
Pseudoephedrine—Body temperature increased—Telmisartan—hypertension	3.11e-05	0.000336	CcSEcCtD
Pseudoephedrine—Decreased appetite—Betaxolol—hypertension	3.11e-05	0.000336	CcSEcCtD
Pseudoephedrine—Dyspnoea—Losartan—hypertension	3.11e-05	0.000336	CcSEcCtD
Pseudoephedrine—Anxiety—Ramipril—hypertension	3.11e-05	0.000336	CcSEcCtD
Pseudoephedrine—Dizziness—Eplerenone—hypertension	3.1e-05	0.000335	CcSEcCtD
Pseudoephedrine—Vomiting—Diltiazem—hypertension	3.1e-05	0.000335	CcSEcCtD
Pseudoephedrine—Vomiting—Indapamide—hypertension	3.1e-05	0.000335	CcSEcCtD
Pseudoephedrine—Asthenia—Valsartan—hypertension	3.09e-05	0.000334	CcSEcCtD
Pseudoephedrine—Hypertension—Timolol—hypertension	3.09e-05	0.000334	CcSEcCtD
Pseudoephedrine—Pain—Furosemide—hypertension	3.09e-05	0.000334	CcSEcCtD
Pseudoephedrine—Asthenia—Olmesartan—hypertension	3.08e-05	0.000332	CcSEcCtD
Pseudoephedrine—Dizziness—Nifedipine—hypertension	3.07e-05	0.000332	CcSEcCtD
Pseudoephedrine—Rash—Diltiazem—hypertension	3.07e-05	0.000332	CcSEcCtD
Pseudoephedrine—Rash—Indapamide—hypertension	3.07e-05	0.000332	CcSEcCtD
Pseudoephedrine—Dermatitis—Diltiazem—hypertension	3.07e-05	0.000332	CcSEcCtD
Pseudoephedrine—Dermatitis—Indapamide—hypertension	3.07e-05	0.000332	CcSEcCtD
Pseudoephedrine—Dyspepsia—Losartan—hypertension	3.07e-05	0.000331	CcSEcCtD
Pseudoephedrine—Vomiting—Carvedilol—hypertension	3.07e-05	0.000331	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Perindopril—hypertension	3.06e-05	0.000331	CcSEcCtD
Pseudoephedrine—Dizziness—Verapamil—hypertension	3.06e-05	0.000331	CcSEcCtD
Pseudoephedrine—Pain—Betaxolol—hypertension	3.06e-05	0.00033	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Irbesartan—hypertension	3.05e-05	0.00033	CcSEcCtD
Pseudoephedrine—Headache—Diltiazem—hypertension	3.05e-05	0.00033	CcSEcCtD
Pseudoephedrine—Headache—Indapamide—hypertension	3.05e-05	0.00033	CcSEcCtD
Pseudoephedrine—Chest pain—Timolol—hypertension	3.05e-05	0.000329	CcSEcCtD
Pseudoephedrine—Rash—Carvedilol—hypertension	3.04e-05	0.000329	CcSEcCtD
Pseudoephedrine—Dermatitis—Carvedilol—hypertension	3.04e-05	0.000328	CcSEcCtD
Pseudoephedrine—Anxiety—Timolol—hypertension	3.04e-05	0.000328	CcSEcCtD
Pseudoephedrine—Vomiting—Doxazosin—hypertension	3.03e-05	0.000328	CcSEcCtD
Pseudoephedrine—Decreased appetite—Losartan—hypertension	3.03e-05	0.000327	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Hydrochlorothiazide—hypertension	3.03e-05	0.000327	CcSEcCtD
Pseudoephedrine—Body temperature increased—Captopril—hypertension	3.02e-05	0.000327	CcSEcCtD
Pseudoephedrine—Headache—Carvedilol—hypertension	3.02e-05	0.000326	CcSEcCtD
Pseudoephedrine—Confusional state—Ramipril—hypertension	3.01e-05	0.000326	CcSEcCtD
Pseudoephedrine—Rash—Doxazosin—hypertension	3.01e-05	0.000325	CcSEcCtD
Pseudoephedrine—Dermatitis—Doxazosin—hypertension	3e-05	0.000325	CcSEcCtD
Pseudoephedrine—Vomiting—Fosinopril—hypertension	2.99e-05	0.000324	CcSEcCtD
Pseudoephedrine—Nausea—Propranolol—hypertension	2.99e-05	0.000323	CcSEcCtD
Pseudoephedrine—Headache—Doxazosin—hypertension	2.99e-05	0.000323	CcSEcCtD
Pseudoephedrine—Vertigo—Lisinopril—hypertension	2.98e-05	0.000322	CcSEcCtD
Pseudoephedrine—Pain—Losartan—hypertension	2.98e-05	0.000322	CcSEcCtD
Pseudoephedrine—Vomiting—Eplerenone—hypertension	2.98e-05	0.000322	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Furosemide—hypertension	2.98e-05	0.000322	CcSEcCtD
Pseudoephedrine—Rash—Fosinopril—hypertension	2.97e-05	0.000321	CcSEcCtD
Pseudoephedrine—Dermatitis—Fosinopril—hypertension	2.97e-05	0.000321	CcSEcCtD
Pseudoephedrine—Vomiting—Nifedipine—hypertension	2.95e-05	0.000319	CcSEcCtD
Pseudoephedrine—Rash—Eplerenone—hypertension	2.95e-05	0.000319	CcSEcCtD
Pseudoephedrine—Headache—Fosinopril—hypertension	2.95e-05	0.000319	CcSEcCtD
Pseudoephedrine—Dermatitis—Eplerenone—hypertension	2.95e-05	0.000319	CcSEcCtD
Pseudoephedrine—Asthenia—Clonidine—hypertension	2.95e-05	0.000318	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Betaxolol—hypertension	2.95e-05	0.000318	CcSEcCtD
Pseudoephedrine—Confusional state—Timolol—hypertension	2.94e-05	0.000318	CcSEcCtD
Pseudoephedrine—Vomiting—Verapamil—hypertension	2.94e-05	0.000318	CcSEcCtD
Pseudoephedrine—Body temperature increased—Perindopril—hypertension	2.94e-05	0.000317	CcSEcCtD
Pseudoephedrine—Palpitations—Lisinopril—hypertension	2.93e-05	0.000317	CcSEcCtD
Pseudoephedrine—Headache—Eplerenone—hypertension	2.93e-05	0.000317	CcSEcCtD
Pseudoephedrine—Rash—Nifedipine—hypertension	2.93e-05	0.000317	CcSEcCtD
Pseudoephedrine—Dermatitis—Nifedipine—hypertension	2.93e-05	0.000316	CcSEcCtD
Pseudoephedrine—Body temperature increased—Irbesartan—hypertension	2.93e-05	0.000316	CcSEcCtD
Pseudoephedrine—Rash—Verapamil—hypertension	2.92e-05	0.000315	CcSEcCtD
Pseudoephedrine—Tachycardia—Ramipril—hypertension	2.92e-05	0.000315	CcSEcCtD
Pseudoephedrine—Dermatitis—Verapamil—hypertension	2.91e-05	0.000315	CcSEcCtD
Pseudoephedrine—Headache—Nifedipine—hypertension	2.91e-05	0.000315	CcSEcCtD
Pseudoephedrine—Body temperature increased—Hydrochlorothiazide—hypertension	2.9e-05	0.000314	CcSEcCtD
Pseudoephedrine—Headache—Verapamil—hypertension	2.9e-05	0.000313	CcSEcCtD
Pseudoephedrine—Nausea—Indapamide—hypertension	2.89e-05	0.000313	CcSEcCtD
Pseudoephedrine—Nausea—Diltiazem—hypertension	2.89e-05	0.000313	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Ramipril—hypertension	2.89e-05	0.000312	CcSEcCtD
Pseudoephedrine—Asthenia—Trandolapril—hypertension	2.87e-05	0.000311	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Losartan—hypertension	2.87e-05	0.00031	CcSEcCtD
Pseudoephedrine—Nausea—Carvedilol—hypertension	2.86e-05	0.00031	CcSEcCtD
Pseudoephedrine—Asthenia—Enalapril—hypertension	2.86e-05	0.000309	CcSEcCtD
Pseudoephedrine—Body temperature increased—Furosemide—hypertension	2.85e-05	0.000309	CcSEcCtD
Pseudoephedrine—Atomoxetine—HTR1B—hypertension	2.85e-05	0.00997	CrCbGaD
Pseudoephedrine—Dizziness—Valsartan—hypertension	2.85e-05	0.000308	CcSEcCtD
Pseudoephedrine—Anorexia—Ramipril—hypertension	2.85e-05	0.000308	CcSEcCtD
Pseudoephedrine—Dizziness—Olmesartan—hypertension	2.83e-05	0.000306	CcSEcCtD
Pseudoephedrine—Nausea—Doxazosin—hypertension	2.83e-05	0.000306	CcSEcCtD
Pseudoephedrine—Chest pain—Lisinopril—hypertension	2.83e-05	0.000305	CcSEcCtD
Pseudoephedrine—Body temperature increased—Betaxolol—hypertension	2.83e-05	0.000305	CcSEcCtD
Pseudoephedrine—Amphetamine—SLC6A3—hypertension	2.82e-05	0.00988	CrCbGaD
Pseudoephedrine—Hyperhidrosis—Timolol—hypertension	2.82e-05	0.000305	CcSEcCtD
Pseudoephedrine—Asthenia—Telmisartan—hypertension	2.82e-05	0.000305	CcSEcCtD
Pseudoephedrine—Anxiety—Lisinopril—hypertension	2.82e-05	0.000304	CcSEcCtD
Pseudoephedrine—Nausea—Fosinopril—hypertension	2.8e-05	0.000302	CcSEcCtD
Pseudoephedrine—Anorexia—Timolol—hypertension	2.78e-05	0.000301	CcSEcCtD
Pseudoephedrine—Nausea—Eplerenone—hypertension	2.78e-05	0.000301	CcSEcCtD
Pseudoephedrine—Nausea—Nifedipine—hypertension	2.76e-05	0.000298	CcSEcCtD
Pseudoephedrine—Body temperature increased—Losartan—hypertension	2.75e-05	0.000298	CcSEcCtD
Pseudoephedrine—Nausea—Verapamil—hypertension	2.75e-05	0.000297	CcSEcCtD
Pseudoephedrine—Phentermine—SLC6A4—hypertension	2.75e-05	0.00961	CrCbGaD
Pseudoephedrine—Asthenia—Captopril—hypertension	2.74e-05	0.000297	CcSEcCtD
Pseudoephedrine—Vomiting—Valsartan—hypertension	2.74e-05	0.000296	CcSEcCtD
Pseudoephedrine—Confusional state—Lisinopril—hypertension	2.73e-05	0.000295	CcSEcCtD
Pseudoephedrine—Vomiting—Olmesartan—hypertension	2.73e-05	0.000295	CcSEcCtD
Pseudoephedrine—Rash—Valsartan—hypertension	2.72e-05	0.000294	CcSEcCtD
Pseudoephedrine—Dizziness—Clonidine—hypertension	2.72e-05	0.000294	CcSEcCtD
Pseudoephedrine—Dermatitis—Valsartan—hypertension	2.71e-05	0.000293	CcSEcCtD
Pseudoephedrine—Rash—Olmesartan—hypertension	2.7e-05	0.000292	CcSEcCtD
Pseudoephedrine—Insomnia—Ramipril—hypertension	2.7e-05	0.000292	CcSEcCtD
Pseudoephedrine—Dermatitis—Olmesartan—hypertension	2.7e-05	0.000292	CcSEcCtD
Pseudoephedrine—Headache—Valsartan—hypertension	2.7e-05	0.000292	CcSEcCtD
Pseudoephedrine—Headache—Olmesartan—hypertension	2.69e-05	0.00029	CcSEcCtD
Pseudoephedrine—Asthenia—Perindopril—hypertension	2.66e-05	0.000288	CcSEcCtD
Pseudoephedrine—Dyspnoea—Ramipril—hypertension	2.66e-05	0.000288	CcSEcCtD
Pseudoephedrine—Asthenia—Irbesartan—hypertension	2.66e-05	0.000287	CcSEcCtD
Pseudoephedrine—Dizziness—Trandolapril—hypertension	2.65e-05	0.000286	CcSEcCtD
Pseudoephedrine—Tachycardia—Lisinopril—hypertension	2.64e-05	0.000286	CcSEcCtD
Pseudoephedrine—Insomnia—Timolol—hypertension	2.64e-05	0.000286	CcSEcCtD
Pseudoephedrine—Dizziness—Enalapril—hypertension	2.64e-05	0.000285	CcSEcCtD
Pseudoephedrine—Asthenia—Hydrochlorothiazide—hypertension	2.63e-05	0.000285	CcSEcCtD
Pseudoephedrine—Dyspepsia—Ramipril—hypertension	2.63e-05	0.000284	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Lisinopril—hypertension	2.62e-05	0.000283	CcSEcCtD
Pseudoephedrine—Methamphetamine—SLC6A3—hypertension	2.62e-05	0.00915	CrCbGaD
Pseudoephedrine—Vomiting—Clonidine—hypertension	2.61e-05	0.000282	CcSEcCtD
Pseudoephedrine—Dyspnoea—Timolol—hypertension	2.6e-05	0.000281	CcSEcCtD
Pseudoephedrine—Dizziness—Telmisartan—hypertension	2.6e-05	0.000281	CcSEcCtD
Pseudoephedrine—Decreased appetite—Ramipril—hypertension	2.6e-05	0.000281	CcSEcCtD
Pseudoephedrine—Asthenia—Furosemide—hypertension	2.59e-05	0.00028	CcSEcCtD
Pseudoephedrine—Rash—Clonidine—hypertension	2.59e-05	0.00028	CcSEcCtD
Pseudoephedrine—Dermatitis—Clonidine—hypertension	2.59e-05	0.00028	CcSEcCtD
Pseudoephedrine—Anorexia—Lisinopril—hypertension	2.58e-05	0.000279	CcSEcCtD
Pseudoephedrine—Atomoxetine—SLC6A3—hypertension	2.58e-05	0.00901	CrCbGaD
Pseudoephedrine—Headache—Clonidine—hypertension	2.57e-05	0.000278	CcSEcCtD
Pseudoephedrine—Dyspepsia—Timolol—hypertension	2.57e-05	0.000278	CcSEcCtD
Pseudoephedrine—Methamphetamine—ADRA2A—hypertension	2.56e-05	0.00897	CrCbGaD
Pseudoephedrine—Asthenia—Betaxolol—hypertension	2.56e-05	0.000277	CcSEcCtD
Pseudoephedrine—Nausea—Valsartan—hypertension	2.56e-05	0.000277	CcSEcCtD
Pseudoephedrine—Nausea—Olmesartan—hypertension	2.55e-05	0.000275	CcSEcCtD
Pseudoephedrine—Vomiting—Trandolapril—hypertension	2.55e-05	0.000275	CcSEcCtD
Pseudoephedrine—Decreased appetite—Timolol—hypertension	2.54e-05	0.000274	CcSEcCtD
Pseudoephedrine—Vomiting—Enalapril—hypertension	2.54e-05	0.000274	CcSEcCtD
Pseudoephedrine—Dizziness—Captopril—hypertension	2.53e-05	0.000273	CcSEcCtD
Pseudoephedrine—Rash—Trandolapril—hypertension	2.53e-05	0.000273	CcSEcCtD
Pseudoephedrine—Dermatitis—Trandolapril—hypertension	2.52e-05	0.000273	CcSEcCtD
Pseudoephedrine—Rash—Enalapril—hypertension	2.51e-05	0.000272	CcSEcCtD
Pseudoephedrine—Dermatitis—Enalapril—hypertension	2.51e-05	0.000272	CcSEcCtD
Pseudoephedrine—Headache—Trandolapril—hypertension	2.51e-05	0.000271	CcSEcCtD
Pseudoephedrine—Vomiting—Telmisartan—hypertension	2.5e-05	0.00027	CcSEcCtD
Pseudoephedrine—Benzyl alcohol—CYP1A1—hypertension	2.5e-05	0.00875	CrCbGaD
Pseudoephedrine—Asthenia—Losartan—hypertension	2.5e-05	0.00027	CcSEcCtD
Pseudoephedrine—Headache—Enalapril—hypertension	2.5e-05	0.00027	CcSEcCtD
Pseudoephedrine—Pain—Timolol—hypertension	2.5e-05	0.00027	CcSEcCtD
Pseudoephedrine—Rash—Telmisartan—hypertension	2.48e-05	0.000268	CcSEcCtD
Pseudoephedrine—Dermatitis—Telmisartan—hypertension	2.48e-05	0.000268	CcSEcCtD
Pseudoephedrine—Headache—Telmisartan—hypertension	2.46e-05	0.000266	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Ramipril—hypertension	2.46e-05	0.000266	CcSEcCtD
Pseudoephedrine—Dizziness—Perindopril—hypertension	2.46e-05	0.000265	CcSEcCtD
Pseudoephedrine—Insomnia—Lisinopril—hypertension	2.45e-05	0.000265	CcSEcCtD
Pseudoephedrine—Dizziness—Irbesartan—hypertension	2.45e-05	0.000265	CcSEcCtD
Pseudoephedrine—Nausea—Clonidine—hypertension	2.44e-05	0.000264	CcSEcCtD
Pseudoephedrine—Vomiting—Captopril—hypertension	2.43e-05	0.000263	CcSEcCtD
Pseudoephedrine—Dizziness—Hydrochlorothiazide—hypertension	2.43e-05	0.000262	CcSEcCtD
Pseudoephedrine—Dyspnoea—Lisinopril—hypertension	2.42e-05	0.000261	CcSEcCtD
Pseudoephedrine—Rash—Captopril—hypertension	2.41e-05	0.000261	CcSEcCtD
Pseudoephedrine—Dermatitis—Captopril—hypertension	2.41e-05	0.00026	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Timolol—hypertension	2.41e-05	0.00026	CcSEcCtD
Pseudoephedrine—Headache—Captopril—hypertension	2.4e-05	0.000259	CcSEcCtD
Pseudoephedrine—Dizziness—Furosemide—hypertension	2.39e-05	0.000258	CcSEcCtD
Pseudoephedrine—Dyspepsia—Lisinopril—hypertension	2.38e-05	0.000258	CcSEcCtD
Pseudoephedrine—Nausea—Trandolapril—hypertension	2.38e-05	0.000257	CcSEcCtD
Pseudoephedrine—Nausea—Enalapril—hypertension	2.37e-05	0.000256	CcSEcCtD
Pseudoephedrine—Dizziness—Betaxolol—hypertension	2.36e-05	0.000256	CcSEcCtD
Pseudoephedrine—Vomiting—Perindopril—hypertension	2.36e-05	0.000255	CcSEcCtD
Pseudoephedrine—Body temperature increased—Ramipril—hypertension	2.36e-05	0.000255	CcSEcCtD
Pseudoephedrine—Decreased appetite—Lisinopril—hypertension	2.36e-05	0.000255	CcSEcCtD
Pseudoephedrine—Vomiting—Irbesartan—hypertension	2.35e-05	0.000254	CcSEcCtD
Pseudoephedrine—Rash—Perindopril—hypertension	2.34e-05	0.000253	CcSEcCtD
Pseudoephedrine—Dermatitis—Perindopril—hypertension	2.34e-05	0.000253	CcSEcCtD
Pseudoephedrine—Nausea—Telmisartan—hypertension	2.34e-05	0.000253	CcSEcCtD
Pseudoephedrine—Vomiting—Hydrochlorothiazide—hypertension	2.33e-05	0.000252	CcSEcCtD
Pseudoephedrine—Rash—Irbesartan—hypertension	2.33e-05	0.000252	CcSEcCtD
Pseudoephedrine—Dermatitis—Irbesartan—hypertension	2.33e-05	0.000252	CcSEcCtD
Pseudoephedrine—Headache—Perindopril—hypertension	2.33e-05	0.000252	CcSEcCtD
Pseudoephedrine—Headache—Irbesartan—hypertension	2.32e-05	0.000251	CcSEcCtD
Pseudoephedrine—Pain—Lisinopril—hypertension	2.32e-05	0.00025	CcSEcCtD
Pseudoephedrine—Rash—Hydrochlorothiazide—hypertension	2.32e-05	0.00025	CcSEcCtD
Pseudoephedrine—Dermatitis—Hydrochlorothiazide—hypertension	2.31e-05	0.00025	CcSEcCtD
Pseudoephedrine—Body temperature increased—Timolol—hypertension	2.31e-05	0.00025	CcSEcCtD
Pseudoephedrine—Dizziness—Losartan—hypertension	2.3e-05	0.000249	CcSEcCtD
Pseudoephedrine—Headache—Hydrochlorothiazide—hypertension	2.3e-05	0.000249	CcSEcCtD
Pseudoephedrine—Vomiting—Furosemide—hypertension	2.3e-05	0.000248	CcSEcCtD
Pseudoephedrine—Rash—Furosemide—hypertension	2.28e-05	0.000246	CcSEcCtD
Pseudoephedrine—Dermatitis—Furosemide—hypertension	2.27e-05	0.000246	CcSEcCtD
Pseudoephedrine—Vomiting—Betaxolol—hypertension	2.27e-05	0.000246	CcSEcCtD
Pseudoephedrine—Nausea—Captopril—hypertension	2.27e-05	0.000246	CcSEcCtD
Pseudoephedrine—Headache—Furosemide—hypertension	2.26e-05	0.000245	CcSEcCtD
Pseudoephedrine—Rash—Betaxolol—hypertension	2.25e-05	0.000244	CcSEcCtD
Pseudoephedrine—Dermatitis—Betaxolol—hypertension	2.25e-05	0.000243	CcSEcCtD
Pseudoephedrine—Headache—Betaxolol—hypertension	2.24e-05	0.000242	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Lisinopril—hypertension	2.23e-05	0.000241	CcSEcCtD
Pseudoephedrine—Vomiting—Losartan—hypertension	2.22e-05	0.000239	CcSEcCtD
Pseudoephedrine—Nausea—Perindopril—hypertension	2.21e-05	0.000238	CcSEcCtD
Pseudoephedrine—Nausea—Irbesartan—hypertension	2.2e-05	0.000238	CcSEcCtD
Pseudoephedrine—Rash—Losartan—hypertension	2.2e-05	0.000237	CcSEcCtD
Pseudoephedrine—Dermatitis—Losartan—hypertension	2.19e-05	0.000237	CcSEcCtD
Pseudoephedrine—Headache—Losartan—hypertension	2.18e-05	0.000236	CcSEcCtD
Pseudoephedrine—Nausea—Hydrochlorothiazide—hypertension	2.18e-05	0.000236	CcSEcCtD
Pseudoephedrine—Nausea—Furosemide—hypertension	2.14e-05	0.000232	CcSEcCtD
Pseudoephedrine—Asthenia—Ramipril—hypertension	2.14e-05	0.000232	CcSEcCtD
Pseudoephedrine—Body temperature increased—Lisinopril—hypertension	2.14e-05	0.000232	CcSEcCtD
Pseudoephedrine—Nausea—Betaxolol—hypertension	2.12e-05	0.00023	CcSEcCtD
Pseudoephedrine—Amphetamine—SLC6A4—hypertension	2.11e-05	0.00739	CrCbGaD
Pseudoephedrine—Amphetamine—DRD2—hypertension	2.1e-05	0.00735	CrCbGaD
Pseudoephedrine—Asthenia—Timolol—hypertension	2.1e-05	0.000226	CcSEcCtD
Pseudoephedrine—Nausea—Losartan—hypertension	2.07e-05	0.000224	CcSEcCtD
Pseudoephedrine—Dizziness—Ramipril—hypertension	1.98e-05	0.000214	CcSEcCtD
Pseudoephedrine—Methamphetamine—SLC6A4—hypertension	1.96e-05	0.00685	CrCbGaD
Pseudoephedrine—Asthenia—Lisinopril—hypertension	1.94e-05	0.00021	CcSEcCtD
Pseudoephedrine—Dizziness—Timolol—hypertension	1.93e-05	0.000209	CcSEcCtD
Pseudoephedrine—Atomoxetine—SLC6A4—hypertension	1.93e-05	0.00674	CrCbGaD
Pseudoephedrine—Vomiting—Ramipril—hypertension	1.9e-05	0.000205	CcSEcCtD
Pseudoephedrine—Rash—Ramipril—hypertension	1.88e-05	0.000204	CcSEcCtD
Pseudoephedrine—Dermatitis—Ramipril—hypertension	1.88e-05	0.000203	CcSEcCtD
Pseudoephedrine—Headache—Ramipril—hypertension	1.87e-05	0.000202	CcSEcCtD
Pseudoephedrine—Vomiting—Timolol—hypertension	1.86e-05	0.000201	CcSEcCtD
Pseudoephedrine—Rash—Timolol—hypertension	1.84e-05	0.000199	CcSEcCtD
Pseudoephedrine—Dermatitis—Timolol—hypertension	1.84e-05	0.000199	CcSEcCtD
Pseudoephedrine—Headache—Timolol—hypertension	1.83e-05	0.000198	CcSEcCtD
Pseudoephedrine—Dizziness—Lisinopril—hypertension	1.79e-05	0.000194	CcSEcCtD
Pseudoephedrine—Nausea—Ramipril—hypertension	1.77e-05	0.000192	CcSEcCtD
Pseudoephedrine—Nausea—Timolol—hypertension	1.73e-05	0.000188	CcSEcCtD
Pseudoephedrine—Vomiting—Lisinopril—hypertension	1.72e-05	0.000186	CcSEcCtD
Pseudoephedrine—Rash—Lisinopril—hypertension	1.71e-05	0.000185	CcSEcCtD
Pseudoephedrine—Dermatitis—Lisinopril—hypertension	1.71e-05	0.000184	CcSEcCtD
Pseudoephedrine—Headache—Lisinopril—hypertension	1.7e-05	0.000183	CcSEcCtD
Pseudoephedrine—Nausea—Lisinopril—hypertension	1.61e-05	0.000174	CcSEcCtD
Pseudoephedrine—Atomoxetine—HTR2A—hypertension	1.48e-05	0.00518	CrCbGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PIK3R1—hypertension	7.86e-07	9.35e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PPARA—hypertension	7.81e-07	9.29e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ADCY5—hypertension	7.79e-07	9.26e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PRKCB—hypertension	7.77e-07	9.25e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FN1—hypertension	7.77e-07	9.25e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—F2—hypertension	7.77e-07	9.25e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOB—hypertension	7.74e-07	9.21e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PRKCG—hypertension	7.74e-07	9.2e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTK2—hypertension	7.71e-07	9.17e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ITGB3—hypertension	7.68e-07	9.14e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PRKCA—hypertension	7.68e-07	9.14e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCL8—hypertension	7.68e-07	9.13e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—YWHAZ—hypertension	7.62e-07	9.06e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EDN1—hypertension	7.62e-07	9.06e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NOTCH1—hypertension	7.61e-07	9.05e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—F2—hypertension	7.6e-07	9.04e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PRKCB—hypertension	7.6e-07	9.04e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FN1—hypertension	7.6e-07	9.04e-06	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTGS2—hypertension	7.6e-07	9.04e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AGT—hypertension	7.56e-07	9e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL5—hypertension	7.56e-07	8.99e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TH—hypertension	7.55e-07	8.98e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NGF—hypertension	7.54e-07	8.96e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SPP1—hypertension	7.54e-07	8.96e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CALM2—hypertension	7.52e-07	8.94e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCL8—hypertension	7.5e-07	8.92e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—hypertension	7.45e-07	8.87e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NOTCH1—hypertension	7.44e-07	8.85e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CALM1—hypertension	7.44e-07	8.85e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOE—hypertension	7.41e-07	8.81e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LPL—hypertension	7.39e-07	8.79e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CAV1—hypertension	7.34e-07	8.73e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GCG—hypertension	7.34e-07	8.73e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SLC2A4—hypertension	7.34e-07	8.73e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—H2AFX—hypertension	7.34e-07	8.73e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCR5—hypertension	7.33e-07	8.72e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PRKCD—hypertension	7.33e-07	8.72e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PDGFRB—hypertension	7.33e-07	8.71e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RPS6KB1—hypertension	7.33e-07	8.71e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOA1—hypertension	7.33e-07	8.71e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ADCY5—hypertension	7.24e-07	8.61e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PRKCG—hypertension	7.19e-07	8.55e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR2A—hypertension	7.17e-07	8.53e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—C3—hypertension	7.16e-07	8.52e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PRKCA—hypertension	7.14e-07	8.49e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ITGB3—hypertension	7.14e-07	8.49e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GOT1—hypertension	7.11e-07	8.46e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—YWHAZ—hypertension	7.08e-07	8.42e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—POMC—hypertension	7.08e-07	8.42e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—INS—hypertension	7.04e-07	8.38e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NGF—hypertension	7e-07	8.33e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SPP1—hypertension	7e-07	8.33e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PDGFB—hypertension	6.97e-07	8.29e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCL8—hypertension	6.97e-07	8.29e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGFR1—hypertension	6.94e-07	8.25e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL2—hypertension	6.93e-07	8.24e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—POMC—hypertension	6.93e-07	8.24e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—STK11—hypertension	6.9e-07	8.21e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP19A1—hypertension	6.9e-07	8.21e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—INS—hypertension	6.89e-07	8.19e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HIF1A—hypertension	6.83e-07	8.13e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCR5—hypertension	6.81e-07	8.1e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PRKCD—hypertension	6.81e-07	8.1e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IGF1—hypertension	6.81e-07	8.1e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AGT—hypertension	6.81e-07	8.1e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT2—hypertension	6.81e-07	8.1e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—EGFR—hypertension	6.78e-07	8.06e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL2—hypertension	6.78e-07	8.06e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CALM1—hypertension	6.69e-07	7.96e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOE—hypertension	6.67e-07	7.93e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LEP—hypertension	6.67e-07	7.93e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR2A—hypertension	6.67e-07	7.93e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IGF1—hypertension	6.66e-07	7.92e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT2—hypertension	6.66e-07	7.92e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—C3—hypertension	6.66e-07	7.92e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—EGFR—hypertension	6.63e-07	7.89e-06	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTEN—hypertension	6.63e-07	7.88e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CAV1—hypertension	6.61e-07	7.86e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOA1—hypertension	6.59e-07	7.84e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KDR—hypertension	6.53e-07	7.77e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PDGFB—hypertension	6.48e-07	7.71e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SERPINE1—hypertension	6.47e-07	7.69e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PPARG—hypertension	6.46e-07	7.68e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGFR1—hypertension	6.45e-07	7.67e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—COMT—hypertension	6.42e-07	7.63e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—POMC—hypertension	6.37e-07	7.57e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HIF1A—hypertension	6.35e-07	7.55e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—INS—hypertension	6.33e-07	7.53e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GNB3—hypertension	6.33e-07	7.53e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARGC1A—hypertension	6.33e-07	7.53e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SERPINE1—hypertension	6.33e-07	7.53e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AGT—hypertension	6.32e-07	7.52e-06	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—EP300—hypertension	6.32e-07	7.52e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—HMOX1—hypertension	6.3e-07	7.49e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—AKT1—hypertension	6.3e-07	7.49e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FN1—hypertension	6.29e-07	7.48e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PRKCB—hypertension	6.29e-07	7.48e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—F2—hypertension	6.29e-07	7.48e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGF2—hypertension	6.26e-07	7.45e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RHOA—hypertension	6.24e-07	7.42e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CALM1—hypertension	6.22e-07	7.4e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CAT—hypertension	6.22e-07	7.39e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOE—hypertension	6.2e-07	7.37e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LEP—hypertension	6.2e-07	7.37e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3R1—hypertension	6.18e-07	7.34e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NOS3—hypertension	6.18e-07	7.34e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GNAS—hypertension	6.16e-07	7.33e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOTCH1—hypertension	6.16e-07	7.32e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CAV1—hypertension	6.14e-07	7.3e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOA1—hypertension	6.13e-07	7.29e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGF2—hypertension	6.13e-07	7.28e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RHOA—hypertension	6.1e-07	7.26e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KDR—hypertension	6.07e-07	7.22e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3R1—hypertension	6.04e-07	7.18e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NOS3—hypertension	6.04e-07	7.18e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOB—hypertension	6.03e-07	7.18e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GSTM1—hypertension	5.87e-07	6.98e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PRKCB—hypertension	5.84e-07	6.95e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FN1—hypertension	5.84e-07	6.95e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—F2—hypertension	5.84e-07	6.95e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RELA—hypertension	5.81e-07	6.91e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ALB—hypertension	5.8e-07	6.9e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—LPL—hypertension	5.76e-07	6.85e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—POMC—hypertension	5.73e-07	6.81e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOTCH1—hypertension	5.72e-07	6.8e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MTOR—hypertension	5.7e-07	6.78e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—INS—hypertension	5.7e-07	6.78e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RELA—hypertension	5.69e-07	6.76e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ADCY5—hypertension	5.64e-07	6.71e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GPX1—hypertension	5.62e-07	6.69e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL2—hypertension	5.61e-07	6.67e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MTOR—hypertension	5.58e-07	6.63e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PRKCA—hypertension	5.56e-07	6.62e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP1A1—hypertension	5.56e-07	6.62e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3R1—hypertension	5.55e-07	6.6e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NOS3—hypertension	5.55e-07	6.6e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IGF1—hypertension	5.51e-07	6.55e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT2—hypertension	5.51e-07	6.55e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—EGFR—hypertension	5.48e-07	6.52e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCL8—hypertension	5.48e-07	6.51e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CD36—hypertension	5.47e-07	6.51e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCL8—hypertension	5.36e-07	6.37e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—POMC—hypertension	5.32e-07	6.33e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—INS—hypertension	5.29e-07	6.3e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AKT1—hypertension	5.29e-07	6.29e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SERPINE1—hypertension	5.23e-07	6.22e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL6—hypertension	5.21e-07	6.2e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL2—hypertension	5.21e-07	6.19e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MTHFR—hypertension	5.19e-07	6.17e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AKT1—hypertension	5.18e-07	6.16e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IGF1—hypertension	5.12e-07	6.09e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT2—hypertension	5.12e-07	6.09e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL6—hypertension	5.1e-07	6.06e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—EGFR—hypertension	5.1e-07	6.06e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARA—hypertension	5.09e-07	6.05e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGS2—hypertension	5.08e-07	6.04e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGF2—hypertension	5.07e-07	6.03e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RHOA—hypertension	5.05e-07	6e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOS3—hypertension	5e-07	5.94e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3R1—hypertension	5e-07	5.94e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MMP9—hypertension	4.95e-07	5.89e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CDKN1A—hypertension	4.94e-07	5.87e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AGT—hypertension	4.93e-07	5.86e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PTEN—hypertension	4.93e-07	5.86e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SERPINE1—hypertension	4.86e-07	5.78e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MMP9—hypertension	4.85e-07	5.76e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CALM1—hypertension	4.85e-07	5.76e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CDKN1A—hypertension	4.83e-07	5.74e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOE—hypertension	4.83e-07	5.74e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MAPK8—hypertension	4.82e-07	5.73e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PTEN—hypertension	4.82e-07	5.73e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AKT1—hypertension	4.81e-07	5.72e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CAV1—hypertension	4.78e-07	5.69e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOA1—hypertension	4.77e-07	5.68e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MAPK8—hypertension	4.71e-07	5.61e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGF2—hypertension	4.71e-07	5.6e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RELA—hypertension	4.7e-07	5.59e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AKT1—hypertension	4.7e-07	5.59e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EP300—hypertension	4.7e-07	5.59e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RHOA—hypertension	4.69e-07	5.58e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3R1—hypertension	4.64e-07	5.52e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOS3—hypertension	4.64e-07	5.52e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MTOR—hypertension	4.61e-07	5.49e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EP300—hypertension	4.6e-07	5.47e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SRC—hypertension	4.57e-07	5.43e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SRC—hypertension	4.47e-07	5.31e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VEGFA—hypertension	4.45e-07	5.29e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCL8—hypertension	4.43e-07	5.27e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTEN—hypertension	4.43e-07	5.27e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RELA—hypertension	4.37e-07	5.2e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VEGFA—hypertension	4.35e-07	5.18e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MTOR—hypertension	4.29e-07	5.1e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AKT1—hypertension	4.28e-07	5.09e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—EP300—hypertension	4.22e-07	5.02e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL6—hypertension	4.21e-07	5.01e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARG—hypertension	4.21e-07	5e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—POMC—hypertension	4.15e-07	4.93e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—INS—hypertension	4.13e-07	4.91e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCL8—hypertension	4.12e-07	4.9e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MYC—hypertension	4.09e-07	4.87e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TGFB1—hypertension	4.08e-07	4.86e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MMP9—hypertension	4.01e-07	4.77e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MYC—hypertension	4e-07	4.76e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EGFR—hypertension	4e-07	4.76e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TGFB1—hypertension	3.99e-07	4.75e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CDKN1A—hypertension	3.99e-07	4.75e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTEN—hypertension	3.99e-07	4.74e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AKT1—hypertension	3.98e-07	4.73e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EGFR—hypertension	3.92e-07	4.66e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL6—hypertension	3.92e-07	4.66e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MAPK8—hypertension	3.9e-07	4.64e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKT1—hypertension	3.89e-07	4.62e-06	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AKT1—hypertension	3.82e-07	4.54e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EP300—hypertension	3.8e-07	4.52e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ALB—hypertension	3.78e-07	4.5e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MMP9—hypertension	3.72e-07	4.43e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CDKN1A—hypertension	3.71e-07	4.41e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTEN—hypertension	3.7e-07	4.4e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SRC—hypertension	3.7e-07	4.4e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MAPK8—hypertension	3.62e-07	4.31e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NOS3—hypertension	3.62e-07	4.3e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3R1—hypertension	3.62e-07	4.3e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKT1—hypertension	3.61e-07	4.3e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VEGFA—hypertension	3.6e-07	4.28e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EP300—hypertension	3.53e-07	4.2e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SRC—hypertension	3.43e-07	4.08e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—hypertension	3.36e-07	4e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VEGFA—hypertension	3.34e-07	3.98e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MYC—hypertension	3.31e-07	3.94e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS2—hypertension	3.31e-07	3.94e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TGFB1—hypertension	3.3e-07	3.93e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—hypertension	3.29e-07	3.91e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGFR—hypertension	3.24e-07	3.85e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MYC—hypertension	3.08e-07	3.66e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL6—hypertension	3.08e-07	3.66e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TGFB1—hypertension	3.07e-07	3.65e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL6—hypertension	3.01e-07	3.58e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGFR—hypertension	3.01e-07	3.58e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTEN—hypertension	2.89e-07	3.43e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT1—hypertension	2.84e-07	3.38e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT1—hypertension	2.78e-07	3.3e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—EP300—hypertension	2.75e-07	3.27e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—hypertension	2.72e-07	3.23e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AKT1—hypertension	2.55e-07	3.04e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—hypertension	2.53e-07	3.01e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL6—hypertension	2.49e-07	2.96e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL6—hypertension	2.31e-07	2.75e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT1—hypertension	2.3e-07	2.73e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT1—hypertension	2.13e-07	2.54e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AKT1—hypertension	1.66e-07	1.98e-06	CbGpPWpGaD
